Suppr超能文献

基于哌嗪的多巴胺受体配体库的多组分合成及生物学评价

Multicomponent Synthesis and Biological Evaluation of a Piperazine-Based Dopamine Receptor Ligand Library.

作者信息

Stucchi Mattia, Gmeiner Peter, Huebner Harald, Rainoldi Giulia, Sacchetti Alessandro, Silvani Alessandra, Lesma Giordano

机构信息

Dipartimento di Chimica, Universit degli Studi di Milano , via Golgi 19, 20133 Milano, Italy.

Department of Chemistry and Pharmacy Emil Fischer Center, Friedrich Alexander University , Schuhstraße 19, D-91052 Erlangen, Germany.

出版信息

ACS Med Chem Lett. 2015 Jun 23;6(8):882-7. doi: 10.1021/acsmedchemlett.5b00131. eCollection 2015 Aug 13.

Abstract

A series of 1,4-disubstituted piperazine-based compounds were designed, synthesized, and evaluated as dopamine D2/D3 receptor ligands. The synthesis relies on the key multicomponent split-Ugi reaction, assessing its great potential in generating chemical diversity around the piperazine core. With the aim of evaluating the effect of such diversity on the dopamine receptor affinity, a small library of compounds was prepared, applying post-Ugi transformations. Ligand stimulated binding assays indicated that some compounds show a significant affinity, with K i values up to 53 nM for the D2 receptor. Molecular docking studies with the D2 and D3 receptor homology models were also performed on selected compounds. They highlighted key interactions at the indole head and at the piperazine moiety, which resulted in good agreement with the known pharmacophore models, thus helping to explain the observed structure-activity relationship data. Molecular insights from this study could enable a rational improvement of the split-Ugi primary scaffold, toward more selective ligands.

摘要

设计、合成并评估了一系列基于1,4 - 二取代哌嗪的化合物作为多巴胺D2/D3受体配体。合成过程依赖关键的多组分拆分 - Ugi反应,评估其在哌嗪核心周围产生化学多样性方面的巨大潜力。为了评估这种多样性对多巴胺受体亲和力的影响,通过Ugi反应后转化制备了一个小型化合物库。配体刺激结合试验表明,一些化合物表现出显著的亲和力,D2受体的Ki值高达53 nM。还对选定的化合物进行了与D2和D3受体同源模型的分子对接研究。这些研究突出了吲哚头部和哌嗪部分的关键相互作用,这与已知的药效团模型高度一致,从而有助于解释观察到的构效关系数据。这项研究的分子见解能够合理改进拆分 - Ugi初级支架,以获得更具选择性的配体。

相似文献

1
Multicomponent Synthesis and Biological Evaluation of a Piperazine-Based Dopamine Receptor Ligand Library.
ACS Med Chem Lett. 2015 Jun 23;6(8):882-7. doi: 10.1021/acsmedchemlett.5b00131. eCollection 2015 Aug 13.
5
Synthesis and evaluation of C9 alkoxy analogues of (-)-stepholidine as dopamine receptor ligands.
Eur J Med Chem. 2017 Jan 5;125:255-268. doi: 10.1016/j.ejmech.2016.09.036. Epub 2016 Sep 14.
6
8
Synthesis, pharmacological evaluation and molecular modeling studies of triazole containing dopamine D3 receptor ligands.
Bioorg Med Chem Lett. 2015 Feb 1;25(3):519-23. doi: 10.1016/j.bmcl.2014.12.023. Epub 2014 Dec 17.
9
Structure-Based Virtual Screening for Dopamine D2 Receptor Ligands as Potential Antipsychotics.
ChemMedChem. 2016 Apr 5;11(7):718-29. doi: 10.1002/cmdc.201500599. Epub 2016 Mar 18.

引用本文的文献

1
Enantiopure β-isocyano-boronic esters: synthesis and exploitation in isocyanide-based multicomponent reactions.
Mol Divers. 2023 Oct;27(5):2161-2168. doi: 10.1007/s11030-022-10549-8. Epub 2022 Oct 19.
2
Isonitrile-Based Multicomponent Synthesis of β-Amino Boronic Acids as β-Lactamase Inhibitors.
Antibiotics (Basel). 2020 May 12;9(5):249. doi: 10.3390/antibiotics9050249.
4
Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D Receptor (DR) Biased Agonism.
J Med Chem. 2017 Apr 13;60(7):2890-2907. doi: 10.1021/acs.jmedchem.6b01875. Epub 2017 Mar 16.

本文引用的文献

3
Asymmetric Ugi 3CR on isatin-derived ketimine: synthesis of chiral 3,3-disubstituted 3-aminooxindole derivatives.
Beilstein J Org Chem. 2014 Jun 18;10:1383-9. doi: 10.3762/bjoc.10.141. eCollection 2014.
9
Dopamine D3 receptor antagonists: a patent review (2007 - 2012).
Expert Opin Ther Pat. 2013 Mar;23(3):363-81. doi: 10.1517/13543776.2013.757593. Epub 2013 Jan 3.
10
An efficient synthesis of symmetric and unsymmetric bis-(β-aminoamides) via Ugi multicomponent reaction.
Org Lett. 2012 Dec 7;14(23):6044-7. doi: 10.1021/ol302935y. Epub 2012 Nov 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验